[1] Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol, 2020; 76, 2982−3021.
[2] Institute for Health Metrics and Evaluation (IHME). GBD results. https://vizhub.healthdata.org/gbd-results/. [2026-03-05]
[3] Liu MB, He XY, Yang XH, et al. Interpretation of annual report on cardiovascular health and diseases in China 2024. Biomed Environ Sci, 2025; 38, 893−917.
[4] Chirinos JA, Segers P, Hughes T, et al. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol, 2019; 74, 1237−63.
[5] Liu S, Liu FC, Li JX, et al. Association between fruit and vegetable intake and arterial stiffness: the China-PAR project. Biomed Environ Sci, 2023; 36, 1113−22.
[6] Germano-Soares AH, Andrade-Lima A, Menêses AL, et al. Association of time spent in physical activities and sedentary behaviors with carotid-femoral pulse wave velocity: a systematic review and meta-analysis. Atherosclerosis, 2018; 269, 211−8. doi:  10.1016/j.atherosclerosis.2018.01.009
[7] Tomiyama H, Hashimoto H, Tanaka H, et al. Continuous smoking and progression of arterial stiffening: a prospective study. J Am Coll Cardiol, 2010; 55, 1979−87. doi:  10.1016/j.jacc.2009.12.042
[8] Zhang DD, Chen WL, Gu MQ, et al. Sex Disparities in the association of blood pressure parameters and arterial sclerosis risk. Biomed Environ Sci, 2024; 37, 795−9.
[9] Wang F, Ye P, Luo LM, et al. Association of serum lipids with arterial stiffness in a population-based study in Beijing. Eur J Clin Invest, 2011; 41, 929−36. doi:  10.1111/j.1365-2362.2011.02481.x
[10] Liu JH, Fan FF, Liu B, et al. Association between remnant cholesterol and arterial stiffness in a Chinese community-based population: a cross-sectional study. Front Cardiovasc Med, 2022; 9, 993097. doi:  10.3389/fcvm.2022.993097
[11] Wang L, Zhi F, Gao BB, et al. Association between lipid profiles and arterial stiffness: a secondary analysis based on a cross-sectional study. J Int Med Res, 2020; 48, 1−7.
[12] Li BQ, Zhou X, Liu Y, et al. Remnant cholesterol is more strongly associated with arterial stiffness than traditional lipids and lipid ratios in the general Chinese population. J Atheroscler Thromb, 2024; 31, 587−602. doi:  10.5551/jat.64146
[13] Zhao WW, Gong W, Wu N, et al. Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese. Lipids Health Dis, 2014; 13, 37. doi:  10.1186/1476-511X-13-37
[14] Nagayama D, Watanabe Y, Saiki A, et al. Lipid parameters are independently associated with cardio-ankle vascular index (CAVI) in healthy Japanese subjects. J Atheroscler Thromb, 2018; 25, 621−33. doi:  10.5551/jat.42291
[15] Wen J, Huang Y, Lu Y, et al. Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population. Hypertens Res, 2019; 42, 1223−30. doi:  10.1038/s41440-019-0251-5
[16] Zhan BM, Huang X, Wang JC, et al. Association between lipid profiles and arterial stiffness in Chinese patients with hypertension: insights from the CSPPT. Angiology, 2019; 70, 515−22. doi:  10.1177/0003319718823341
[17] Zhang YY, Vittinghoff E, Pletcher MJ, et al. Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events. J Am Coll Cardiol, 2019; 74, 330−41. doi:  10.1016/j.jacc.2019.03.529
[18] Wilkins JT, Ning HY, Allen NB, et al. Prediction of cumulative exposure to atherogenic lipids during early adulthood. J Am Coll Cardiol, 2024; 84, 961−73.
[19] Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American heart association. Hypertension, 2015; 66, 698−722. doi:  10.1161/HYP.0000000000000033
[20] Komine H, Asai Y, Yokoi T, et al. Non-invasive assessment of arterial stiffness using oscillometric blood pressure measurement. BioMed Eng OnLine, 2012; 11, 6. doi:  10.1186/1475-925x-11-6
[21] Sasaki-Nakashima R, Kino T, Chen L, et al. Successful prediction of cardiovascular risk by new non-invasive vascular indexes using suprasystolic cuff oscillometric waveform analysis. J Cardiol, 2017; 69, 30−7. doi:  10.1016/j.jjcc.2016.06.004
[22] Zhang YP, Yin P, Xu ZJ, et al. Non-invasive assessment of early atherosclerosis based on new arterial stiffness indices measured with an upper-arm oscillometric device. Tohoku J Exp Med, 2017; 241, 263−70. doi:  10.1620/tjem.241.263
[23] Ueno H, Uchida K, Kawashima H, et al. AI-induced vascular ages are a measurable residual risk for cardiovascular diseases in the Japanese population. J Clin Med, 2025; 14, 4722. doi:  10.3390/jcm14134722
[24] Yamanashi H, Koyamatsu J, Nagayoshi M, et al. Screening validity of arterial pressure-volume index and arterial velocity-pulse index for preclinical atherosclerosis in Japanese community-dwelling adults: the Nagasaki islands study. J Atheroscler Thromb, 2018; 25, 792−8. doi:  10.5551/jat.43125
[25] Yang XL, Li JX, Hu DS, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation, 2016; 134, 1430−40. doi:  10.1161/CIRCULATIONAHA.116.022367
[26] Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA, 2018; 320, 2020−8. doi:  10.1001/jama.2018.14854
[27] Martin SS, Blaha MJ, Elshazly MB, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA, 2013; 310, 2061−8. doi:  10.3410/f.718181797.793487938
[28] Sajja A, Park J, Sathiyakumar V, et al. Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw Open, 2021; 4, e2128817. doi:  10.1001/jamanetworkopen.2021.28817
[29] Wu ZY, Wang JQ, Zhang HP, et al. Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol. BMC Med, 2023; 21, 42. doi:  10.1186/s12916-023-02733-w
[30] Han MH, Huang KY, Shen C, et al. Discordant high remnant cholesterol with LDL-C increases the risk of stroke: a Chinese prospective cohort study. Stroke, 2024; 55, 2066−74. doi:  10.1161/STROKEAHA.124.046811
[31] Li CL, Zhu YD, Ma YJ, et al. Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol, 2022; 79, 1321−35. doi:  10.3410/f.741938187.793592669
[32] Xiao ZW, Lin ZQ, Xu L, et al. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease. Eur J Prev Cardiol, 2023; 30, 1924−34. doi:  10.1093/eurjpc/zwad297
[33] Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ, 2003; 326, 219. doi:  10.1136/bmj.326.7382.219
[34] Pavlovska I, Kunzova S, Jakubik J, et al. Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study. Lipids Health Dis, 2020; 19, 170. doi:  10.1186/s12944-020-01345-0
[35] Chen QW, Huang XZ, Ding Y, et al. Predicting the risk of arterial stiffness in coal miners based on different machine learning models. Biomed Environ Sci, 2024; 37, 108−11. doi:  10.3389/fmed.2022.1037944
[36] Yu SK, McEniery CM. Central versus peripheral artery stiffening and cardiovascular risk. Arterioscler Thromb Vasc Biol, 2020; 40, 1028−33. doi:  10.1161/ATVBAHA.120.313128
[37] Ference BA, Graham I, Tokgozoglu L, et al. Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol, 2018; 72, 1141−56. doi:  10.1016/j.jacc.2018.06.046
[38] Lacolley P, Regnault V, Segers P, et al. Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease. Physiol Rev, 2017; 97, 1555−617. doi:  10.1152/physrev.00003.2017
[39] Badhwar S, Chandran DS, Jaryal AK, et al. Regional arterial stiffness in central and peripheral arteries is differentially related to endothelial dysfunction assessed by brachial flow-mediated dilation in metabolic syndrome. Diab Vasc Dis Res, 2018; 15, 106−13. doi:  10.1177/1479164117748840
[40] Reiner Ž, Simental-Mendía LE, Ruscica M, et al. Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis. Arch Med Sci, 2019; 15, 1365−74. doi:  10.5114/aoms.2019.89450
[41] Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation. Clin Chem, 2021; 67, 143−53. doi:  10.1093/clinchem/hvaa252
[42] Nakamura T, Takano H, Umetani K, et al. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis, 2005; 181, 321−7. doi:  10.1016/j.atherosclerosis.2005.01.012
[43] Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res, 2016; 118, 547−63. doi:  10.1161/CIRCRESAHA.115.306249
[44] Hung CS, Lin JW, Hsu CN, et al. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis, 2009; 19, 241−6. doi:  10.1016/j.numecd.2008.07.006